Veteran Marc Forth Takes the Helm at Jeune Aesthetics
Marc Forth appointed CEO of Jeune Aesthetics to lead next growth phase.


Jeune Aesthetics, the aesthetics-focused arm of Krystal Biotech, is welcoming seasoned industry leader Marc Forth as its new CEO. With more than 30 years of commercial and executive experience—including key leadership roles in the success of globally recognized brands like BOTOX®—Forth steps into this role as Jeune prepares to scale its innovative gene-delivery-based skincare platform. Having served on Jeune’s board since 2021, Forth is no stranger to the company’s mission to redefine skin rejuvenation at the molecular level.
Forth’s resume is steeped in aesthetics and therapeutic commercialization, from steering AEON Biopharma through clinical development to leading divisions at Allergan that launched transformative products. His deep expertise in consumer engagement and brand building will be crucial as Jeune aims to position itself as a category leader in reversing the biology of aging skin. “I’m energized to lead Jeune into its next chapter and bring truly rejuvenative treatments to people around the world,” said Forth.

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
More from Pharma News
All stories →
Bristol-Myers Squibb Gains FDA Accelerated Approval for Iberdomide in Relapsed or Refractory Multiple Myeloma

Eton Pharmaceuticals Gains FDA Fast Track for AMGLIDIA and Targets 2027 NDA with ASN-001 Acquisition

Discussion